Skip to Main Content

Paper Details

The addition of low-dose-rate brachytherapy and androgen-deprivation therapy decreases biochemical failure and prostate cancer death compared with dose-escalated external-beam radiation therapy for high-risk prostate cancer.
Cancer
36
2013

Datasets

Release 1.2